6 news items
Incyte Completes Acquisition of Escient Pharmaceuticals
INCY
30 May 24
and Autoimmunity (IAI) pipeline and reinforces commitment to bring innovative solutions to patients
Incyte Acquires 2 Downtown Wilmington Office Buildings, Expanding Its Presence In Delaware; Financial Terms Not Disclosed
INCY
21 May 24
to be located together as they continue to deliver on their commitment to finding innovative solutions for patients with critical unmet medical needs.
Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings
INCY
21 May 24
the Company's U.S.-based teams to be located together as they continue to deliver on their commitment to finding innovative solutions for patients
Incyte Announces New Data from Phase 2 Study Evaluating Ruxolitinib Cream (Opzelura®) in Patients with Mild-to-Moderate Hidradenitis Suppurativa
INCY
10 Mar 24
formed the foundation of the company. Today, we are building on this legacy as we discover and develop innovative dermatology treatments to bring
Incyte Presents New Late-Breaking Data from Phase 2 Study Evaluating Povorcitinib in Patients with Prurigo Nodularis
INCY
10 Mar 24
formed the foundation of the company. Today, we are building on this legacy as we discover and develop innovative dermatology treatments to bring solutions
1gx0kw9l01tndti68bnlwh9g9y7q52k5zf77a47csgifl
INCY
4 Mar 24
, we are building on this legacy as we discover and develop innovative dermatology treatments to bring solutions to patients in need
- Prev
- 1
- Next